Search dm+d | This AMP cannot be matched against our prescribing data.
| Description | COVID-19 Vaccine Convidecia (Adenovirus Type 5 Vector [recombinant]) 40,000,000,000 viral particles/0.5ml dose solution for injection vials (CanSino Biologics Inc) |
| BNF code | 1404000ATBSAAAZ |
| Virtual Medicinal Product | Generic COVID-19 Vaccine Convidecia (Adenovirus Type 5 Vector [recombinant]) 40,000,000,000 viral particles/0.5ml dose solution for injection vials |
| Name | COVID-19 Vaccine Convidecia (Adenovirus Type 5 Vector [recombinant]) 40,000,000,000 viral particles/0.5ml dose solution for injection vials |
| Abbreviated name | COVID-19 Vaccine Convidecia 0.5ml inj vials |
| Supplier | CanSino Biologics Inc |
| Current licensing authority | None |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | Restricted Availability |
| Actual Medicinal Product Packs | |
|---|---|
| COVID-19 Vaccine Convidecia (Adenovirus Type 5 Vector [recombinant]) 40,000,000,000 viral particles/0.5ml dose solution for injection vials (CanSino Biologics Inc) 1 dose | |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.